Pre-transplant Kidney Function Predicts Chronic Kidney Disease After Liver Transplant: Meta-Analysis of Observational Studies

被引:22
|
作者
Fabrizi, Fabrizio [1 ]
Dixit, Vivek [2 ]
Martin, Paul [3 ]
Messa, Piergiorgio [1 ]
机构
[1] Maggiore Hosp, IRCCS Fdn, Div Nephrol & Dialysis, I-20122 Milan, Italy
[2] Univ Calif Los Angeles, Sch Med, Div Digest Dis, Los Angeles, CA USA
[3] Univ Miami, Sch Med, Div Hepatol, Miami, FL USA
关键词
Liver transplantation; Chronic kidney disease; Incidence; MELD score; CHRONIC-RENAL-FAILURE; RISK-FACTORS; REPLACEMENT THERAPY; CLINICAL-TRIALS; NONRENAL ORGAN; DYSFUNCTION; OUTCOMES; IMPACT; PREVALENCE; RECIPIENTS;
D O I
10.1007/s10620-010-1529-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronic kidney disease is a common problem in long-term survivors after liver transplantation. Several studies to clarify the risk factors for incidence of chronic kidney disease among liver transplant recipients, including preoperative kidney function, have yielded conflicting results. The aim of this study was to conduct a systematic review of the published medical literature on the impact of pre-transplant kidney function on the occurrence of chronic kidney disease after liver transplantation. Study-specific relative risks were weighted by the inverse of their variance to obtain fixed- and random-effects pooled estimates for incidence of chronic kidney disease across the published studies. The relative risk of chronic kidney disease after liver transplantation according to pre-transplant glomerular filtration rate was regarded as the most reliable outcome end-point. We identified seven studies (38,036 unique liver transplant recipients). A stratified analysis including only studies provided with glomerular filtration rate at transplant reported that the summary estimate of relative risk and 95% confidence intervals (CIs) for developing chronic renal failure among liver transplant recipients with diminished renal function at transplant was 2.12 (95% CI, 1.01; 4.46) (random-effects model). The p value for study heterogeneity was significant (p = 0.0001). Post-transplant chronic kidney disease shows impact on survival; the summary estimate for the adjusted relative risk of all-cause mortality with chronic kidney disease after liver transplant was 4.35 (95% confidence Intervals, 3.34; 5.66), p = 0.0001 (random-effects model). An increased risk of chronic kidney disease frequently exists among liver transplant recipients with reduced renal function at transplant. The occurrence of chronic kidney disease after liver transplantation has a major impact on mortality. Additional studies are needed to understand better the natural history of chronic kidney disease among liver transplant recipients.
引用
收藏
页码:1282 / 1289
页数:8
相关论文
共 50 条
  • [21] Pre-Transplant Transcriptomic Signature in Peripheral Blood Predicts Early Acute Rejection after Kidney Transplant.
    Zhang, W.
    Yi, Z.
    Wei, C.
    Keung, K.
    Sun, Z.
    Xi, C.
    Woytovich, C.
    Farouk, S.
    Gallon, L.
    Menon, M.
    Magee, C.
    Najafian, N.
    Samaniego, M.
    Djamali, A.
    Alexander, S.
    Rosales, I.
    Smith, R.
    O'Connell, P.
    Colvin, R.
    Cravedi, P.
    Murphy, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 567 - 567
  • [22] INCREASED MORTALITY AND CHRONIC KIDNEY DISEASE IN PATIENTS RECEIVING RENAL REPLACEMENT THERAPY AFTER LIVER TRANSPLANTATION WITH PRESERVED PRE-TRANSPLANT RENAL FUNCTION
    Tinti, Francesca
    Leithead, Joanna A.
    Mitterhofer, Anna Paola
    Muiesan, Paolo
    Ferguson, James
    TRANSPLANT INTERNATIONAL, 2015, 28 : 661 - 661
  • [23] Impact of Ramadan fasting on kidney function and related outcomes in chronic kidney disease and kidney transplant recipients: a systematic review and meta-analysis
    Bello, Aminu Kasarawa
    Lloyd, Anita
    Osman, Mohamed Abdullahi
    Kurzawa, Julia
    Chambers, Thane
    Habib, Syed
    Olah, Michelle E.
    Habeeb, Zahraa
    Qarni, Uwais
    Shojai, Soroush
    Pauly, Robert Peter
    BMJ OPEN, 2024, 14 (11):
  • [24] Telemedicine in Advanced Kidney Disease and Kidney Transplant: A Qualitative Meta-Analysis of Studies of Patient Perspectives
    Manko, Christopher D.
    Apple, Benjamin J.
    Chang, Alexander R.
    Romagnoli, Katrina M.
    Johannes, Bobbie L.
    KIDNEY MEDICINE, 2024, 6 (07)
  • [25] Outcome of Liver Transplant Recipients with Membranoproliferative Glomerulonephritis (MPGN) on Pre-Transplant Kidney Biopsy
    Wadei, H. M.
    Nur, L.
    Gonwa, T. A.
    Rosser, B. G.
    Satyanarayana, R.
    Mai, M.
    Sibulesky, L.
    Keaveny, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 327 - 327
  • [26] Proteinuria in Diseased Kidney Transplant Donors for Prediction of Chronic Lesions in Pre-Transplant Biopsies - A Prospective Observational Study.
    Haupenthal, F.
    Klaeger, J.
    Bauernfeind, F.
    Heinzel, A.
    Doberer, K.
    Mayer, K.
    Naar, L.
    Eigenschink, M.
    Hu, K.
    Regele, H.
    Szekeres, T.
    Reindl-Schwaighofer, R.
    Bond, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 664 - 665
  • [27] OUTCOMES OF SIMULTANEOUS LIVER KIDNEY TRANSPLANT ARE NOT AFFECTED BY PRE-TRANSPLANT DONOR SPECIFIC ANTIBODIES
    Hanish, S. I.
    Samaniego, M.
    Leverson, G.
    D'alessandro, A. M.
    Fernandez, L. A.
    LIVER TRANSPLANTATION, 2009, 15 (07) : S205 - S205
  • [28] Association of pre-transplant statin use with delayed graft function in kidney transplant recipients
    Reiling, Janske
    Johnson, David W.
    Kruger, Peter S.
    Pillans, Peter
    Wall, Daryl R.
    BMC NEPHROLOGY, 2012, 13
  • [29] Association of pre-transplant statin use with delayed graft function in kidney transplant recipients
    Janske Reiling
    David W Johnson
    Peter S Kruger
    Peter Pillans
    Daryl R Wall
    BMC Nephrology, 13
  • [30] Kidney Transplant Outcome According to Pre-transplant Dialysis Modality
    Schiavelli, Ruben
    Sleiman, Jihan
    Tagliafichi, Viviana
    Juan, Ibanez
    Cora Giordani, Maria
    Hansen, Daniela
    Liliana, Bisigniano
    TRANSPLANTATION, 2022, 106 (09) : S577 - S577